jurisdiction: US

text:
 I
 111th CONGRESS
 2d Session
 H. R. 6083
 IN THE HOUSE OF REPRESENTATIVES
 August 10, 2010
 Mr. Smith of New
 Jersey (for himself, Mr. Davis of
 Alabama, Mr. Pitts,
 Mr. Lipinski, and
 Mr. Fattah) introduced the following
 bill; which was referred to the Committee
 on Energy and Commerce
 A BILL
 To amend the Stem Cell Therapeutic and Research Act of
 2005.
 1.Short titleThis Act may be cited as the
 Stem Cell Therapeutic and Research
 Reauthorization Act of 2010.
 2.Amendments to the
 Stem Cell Therapeutic and Research Act of 2005
 (a)Cord blood
 inventorySection 2 of the Stem Cell Therapeutic and Research Act
 of 2005 (42 U.S.C. 274k note) is amended—
 (1)in subsection (a),
 by inserting at least before 150,000;
 (2)in subsection
 (c)(3), by inserting at least before
 150,000;
 (3)in subsection
 (d)—
 (A)in paragraph (2),
 by striking ; and and inserting ;;
 (B)by redesignating
 paragraph (3) as paragraph (5); and
 (C)by inserting after
 paragraph (2) the following:
 (3)will provide a
 plan to increase cord blood unit collections at collection sites that exist at
 the time of application, assist with the establishment of new collection sites,
 or contract with new collection sites;
 (4)will annually
 provide to the Secretary a plan for, and demonstrate, ongoing measurable
 progress toward achieving self-sufficiency of cord blood unit collection and
 banking operations;
 and
 ;
 (4)in subsection
 (e)—
 (A)in paragraph
 (1)—
 (i)by
 striking 10 years and inserting a period of at least 10
 years beginning on the last date on which the recipient of a contract under
 this section receives Federal funds under this section; and
 (ii)by
 striking the second sentence and inserting The Secretary shall ensure
 that no Federal funds shall be obligated under any such contract after the date
 that is 5 years after the date on which the contract is entered into, except as
 provided in paragraphs (2) and (3).;
 (B)in paragraph
 (2)—
 (i)in
 the matter preceding subparagraph (A)—
 (I)by striking
 Subject to paragraph (1)(B), the and inserting
 The; and
 (II)by striking
 3 and inserting 5;
 (ii)in
 subparagraph (A)—
 (I)by inserting
 at least before 150,000; and
 (II)by striking
 ; and and inserting ;;
 (iii)in
 subparagraph (B)—
 (I)by inserting
 meeting the requirements under subsection (d) after
 receive an application for a contract under this section;
 and
 (II)by striking
 or the Secretary and all that follows through the period at the
 end and inserting ; or; and
 (iv)by
 adding at the end the following:
 (C)the Secretary
 determines that the outstanding inventory need cannot be met by the qualified
 cord blood banks under contract under this
 section.
 ;
 and
 (C)by striking
 paragraph (3) and inserting the following:
 (3)Extension
 eligibilityA qualified cord blood bank shall be eligible for a
 5-year extension of a contract awarded under this section, as described in
 paragraph (2), provided that the qualified cord blood bank—
 (A)demonstrates a
 superior ability to satisfy the requirements described in subsection (b) and
 achieves the overall goals for which the contract was awarded;
 (B)provides a plan
 for how the qualified cord blood bank will increase cord blood unit collections
 at collection sites that exist at the time of consideration for such extension
 of a contract, assist with the establishment of new collection sites, or
 contract with new collection sites; and
 (C)annually provides
 to the Secretary a plan for, and demonstrates, ongoing measurable progress
 toward achieving self-sufficiency of cord blood unit collection and banking
 operations.
 ;
 (5)in subsection
 (g)(4), by striking or parent; and
 (6)in subsection
 (h)—
 (A)by striking
 paragraph (2) and inserting the following:
 (2)Authorization of
 appropriationsThere are authorized to be appropriated to the
 Secretary to carry out the program under this section $23,000,000 for each of
 fiscal years 2011 through 2014 and $20,000,000 for fiscal year 2015. Such funds
 so appropriated shall remain available until
 expended.
 ;
 and
 (B)in paragraph (3),
 by striking in each of fiscal years 2007 through 2009 and
 inserting for fiscal years 2011 through 2015.
 (b)National
 programSection 379 of the Public Health Service Act (42 U.S.C.
 274k) is amended—
 (1)by striking
 subsection (a)(6) and inserting the following:
 (6)The Secretary,
 acting through the Advisory Council, shall submit to Congress an annual report
 on the activities carried out under this
 section.
 ;
 (2)by striking
 subsection (d)(2)(D) and inserting the following:
 (D)support studies
 and demonstration and outreach projects for the purpose of increasing cord
 blood unit donation and collection from a genetically diverse population,
 including exploring novel approaches or incentives, such as remote or other
 innovative technological advances that could be used to collect cord blood
 units, to expand the number of cord blood unit collection sites partnering with
 cord blood banks that receive a contract under the National Cord Blood Bank
 Inventory program under section 2 of the Stem Cell Therapeutic and Research Act
 of 2005;
 ;
 and
 (3)by striking
 subsection (f)(5)(A) and inserting the following:
 (A)require the
 establishment of a system of strict confidentiality to protect the identity and
 privacy of patients and donors in accordance with Federal and State law;
 and
 .
 (c)Authorization of
 appropriationsSection 379B of the Public Health Service Act (42
 U.S.C. 274m) is amended by striking $34,000,000 and all that
 follows through the period at the end, and inserting $30,000,000 for
 each of fiscal years 2011 through 2014 and $33,000,000 for fiscal year 2015.
 Such funds so appropriated shall remain available until
 expended..
 (d)Report on cord
 blood unit donation and collection
 (1)In
 generalNot later than 1 year after the date of enactment of this
 Act, the Comptroller General of the United States shall submit to the Committee
 on Health, Education, Labor, and Pensions and the Committee on Appropriations
 of the Senate, the Committee on Energy and Commerce and the Committee on
 Appropriations of the House of Representatives, and the Secretary of Health and
 Human Services a report reviewing studies, demonstration programs, and outreach
 efforts for the purpose of increasing cord blood unit donation and collection
 for the National Cord Blood Inventory to ensure a high-quality and genetically
 diverse inventory of cord blood units.
 (2)ContentsThe
 report described in paragraph (1) shall include a review of such studies,
 demonstration programs, and outreach efforts under section 2 of the Stem Cell
 Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) (as amended by this
 Act) and section 379 of the Public Health Service Act (42 U.S.C. 274k) (as
 amended by this Act), including—
 (A)a description of
 the challenges and barriers to expanding the number of cord blood unit
 collection sites, including cost, the impact of regulatory and administrative
 requirements, and the capacity of cord blood banks to maintain high-quality
 units;
 (B)remote or other
 innovative technological advances that could be used to collect cord blood
 units;
 (C)appropriate
 methods for improving provider education about collecting cord blood units for
 the national inventory and participation in such collection activities;
 (D)estimates of the
 number of cord blood unit collection sites necessary to meet the outstanding
 national inventory need and the characteristics of such collection sites that
 would help increase the genetic diversity and enhance the quality of cord blood
 units collected;
 (E)best practices for
 establishing and sustaining partnerships for cord blood unit collection at
 medical facilities with a high number of minority births;
 (F)potential and
 proven incentives to encourage hospitals to become cord blood unit collection
 sites and partner with cord blood banks participating in the National Cord
 Blood Inventory under section 2 of the Stem Cell Therapeutic and Research Act
 of 2005 and to assist cord blood banks in expanding the number of cord blood
 unit collection sites with which such cord blood banks partner; and
 (G)recommendations
 about methods cord blood banks and collection sites could use to lower costs
 and improve efficiency of cord blood unit collection without decreasing the
 quality of the cord blood units collected.


type: wikipedia

text:
State Route 99 (SR 99) is part of Maine's system of numbered state highways, located in York County. It runs from an intersection with SR 109 in Sanford to Kennebunk, where it meets SR 9A and U.S. Route 1 (US 1). SR 99 is signed as an east–west route.
 Route description
 SR 99 begins in the west at SR 109 in the southeastern corner of Sanford. The highway crosses into Kennebunk and runs east into town along the Mousam River. SR 99 passes over the Maine Turnpike (Interstate 95) without an interchange before intersecting SR 9A. SR 99 is cosigned with SR 9A into downtown for before the two routes meet US 1. SR 99 ends at this intersection while SR 9A joins up with US 1 north. SR 35 crosses US 1 less than from this intersection.
 The route is also known as Cat Mousam Road (in Kennebunk), Webber Hill Road, and Kennebunk Road (in Sanford). Route 99 also passes by Lloid G. Nedeau Memorial Park.
 History
 SR 99 has always had its administrative terminus at US 1 in Kennebunk, but its signed eastern terminus was historically located at its intersection with SR 9A west of downtown. Signage from US 1 for SR 9A read "To SR 99." Signage has since been updated, and SR 99 is now cosigned with SR 9A between the two historic termini.
 Major junctions
 References
 External links
 099
 Transportation in York County, Maine


type: caselaw

jurisdiction: EU

text:
 7.12.2015
 BG
 Официален вестник на Европейския съюз
 C 406/21
 Жалба, подадена на 23 септември 2015 г. от Siderurgica Latina Martin SpA (SLM) срещу решението, постановено от Общия съд (шести състав) на 15 юли 2015 г. по съединени дела T-389/10 и T-419/10
 (Дело C-505/15 P)
 (2015/C 406/22)
 Език на производството: италиански
 Страни
 Жалбоподател: Siderurgica Latina Martin SpA (SLM) (представители: G. Belotti, P. Ziotti, avvocati)
 Друга страна в производството: Европейска комисия
 Искания на жалбоподателя
 —
 да се намали глобата, наложена на SLM, както при условията на лична, така и на солидарна отговорност, като за тази цел се вземат предвид основно (i) изводите, направени в първоинстанционното производство, (ii) Насоките относно метода за определяне на размера на глобите в сила към момента на разглежданите факти, (iii) незначителната роля на жалбоподателя в картела и краткото му участие в него, което за SLM започва от края на 1999 г., единствената дата, за която са налице непротиворечиви доказателства в преписката, които я подкрепят безспорно,
 —
 да се присъди справедливо обезщетение за забавянето, с което се характеризира третирането от страна на Комисията на искането за освобождаване от глоба или намаляване на нейния размер, въпрос, който е пренебрегнат напълно от Общия съд,
 —
 да се предостави исканото освобождаване от глоба или намаляване на нейния размер за своевременните изявления на жалбоподателя,
 —
 да се присъди справедливо обезщетение за забавянето на съдебното производство,
 —
 във всички случаи да се осъди Комисията да заплати съдебните разноски по делото.
 Основания и основни доводи
 ORI формулира по същество [шест] основания за обжалване, насочени към доказването на това, че Общият съд:
 —
 е намалил в недостатъчна степен наложената на жалбоподателя глоба, по начин, който не съответства на изводите, направени в първоинстанционното производство, и така е нарушил член 49, параграф 3 от Хартата на основните права, както и установените принципи на правото на Съюза, а именно принципа на пропорционалност на санкциите в областта на конкуренцията и задължението за мотивиране,
 —
 е нарушил правото на Европейския съюз относно забраната за прилагане на по-неблагоприятния наказателен закон с обратна сила, и по-специално член 49, параграф 1 от Хартата на основните права, като не е приложил Насоките относно метода за определяне на размера на глобите в сила към момента на разглежданите факти,
 —
 не е упражнил пълен съдебен контрол, като по този начин е нарушил и член 48 от Хартата на основните права, при очевидно неправилна преценка на противоречивите изводи, направени в първоинстанционното производство, пристрастност и липса на мотиви,
 —
 не е взел отношение по твърдяното лошо администриране на преписката от страна на Комисията, дължащо се на забавянето да се разгледа искането за освобождаване от глоба или намаляване на нейния размер, по което Комисията се е произнесла едва шест години след отправянето му,
 —
 не е взел предвид отличителните особености на искането на жалбоподателя за освобождаване от глоба или намаляване на нейния размер, като е стигнал до парадоксалния и явно несправедлив извод, че само създателите на картел могат да се ползват от намаляване на санкцията за оказаното сътрудничество, тъй като разполагат с доказателства с добавена стойност, каквито не могат да притежават останалите предприятия, които играят по-незначителна роля в картела,
 —
 е нарушил член 47 от Хартата на основните права, която гарантира правото дело да бъде разгледано в разумен срок, тъй като са му били необходими 5 години, за да постанови решение.